Please login to the form below

Not currently logged in
Email:
Password:

Boehringer appoints new chairman of the board

Hubertus vonBaumbach will succeed Andreas Barner
Hubert von Baumbach

Boehringer Ingelheim has appointed Hubertus von Baumbach as chairman of the board of managing directors with effect from June 2016.

Baumbach has been a member of the board of managing directors since 2009 and is head of the corporate board division of finance. He has also worked at Roche in the US and at Boehringer Ingelheim in Canada.

His appointment follows the move of the current chair, Andreas Barner, to the shareholders' committee.

Christian Boehringer, chair of the shareholders' committee, said: “This decision provided a successor who would ensure continuity whilst also looking to the future. Hubertus von Baumbach knows the corporation and its various divisions and his time on the board of managing directors has prepared him well for the company's future challenges.   

"Along with colleagues on the board of managing directors, he will continue the drive for change at Boehringer Ingelheim in order to secure the company's independence in the long term.”  

Also joining the board is Michel Pairet who will be responsible for the corporate business division of research and nonclinical development from January 1 2016. He formerly led the pharmacology unit at the research facility in Biberach

Article by
Nikhil Patel

9th November 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics